The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–263 of 263
Braun, J., Baraliakos, X., Listing, J., Fritz, C., Alten, R., Burmester, G. R., Krause, A., Schewe, S., Schneider, M., Sörensen, H., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075879 · Cited by 144
Ogata, A., Tanimura, K., Sugimoto, T., Inoue, H., Urata, Y., Matsubara, T., Kondo, M., Ueki, Y., Iwahashi, M., Tohma, S., et al. (2014) · Arthritis Care & Research · doi:10.1002/acr.22110 · Cited by 140
Adalimumab for treating rheumatoid arthritis
Navarro-Sarabia, F., Ariza‐Ariza, R., Hernández‐Cruz, B., & Villanueva, I. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005113.pub2 · Cited by 140
Genovese, M., Rubbert-Roth, A., Smolen, J., Kremer, J., Khraishi, M., Gómez-Reino, J., Sebba, A., Pilson, R., Williams, S., & van Vollenhoven, R. (2013) · Journal of Rheumatology · doi:10.3899/jrheum.120687 · Cited by 139
Magnano, M. D., Chakravarty, E. F., Broudy, C., Chung, L. S., Kelman, A., Hillygus, J., & Genovese, M. C. (2007) · PubMed · Cited by 135
Smolen, J. S., Ávila, J. C. M., & Aletaha, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200395 · Cited by 135
Graudal, N. A., & Jűrgens, G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27592 · Cited by 135
Dretzke, J., Edlin, R. P., Round, J. A., Connock, M. J., Hulme, C. T., Czeczot, J., Fry-Smith, A., McCabe, C. J., & Meads, C. (2011) · Health Technology Assessment · doi:10.3310/hta15060 · Cited by 134
Horneff, G., Burgos‐Vargas, R., Constantin, T., Foeldvari, I., Vojinović, J., Chasnyk, V. G., Dehoorne, J., Panavienė, V., Sušić, G., Staņēviča, V., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203046 · Cited by 134
Furneri, G., Mantovani, L. G., Belisari, A., Mosca, M., Cristiani, M., Bellelli, S., Cortesi, P. A., & Turchetti, G. (2012) · PubMed · Cited by 129
Which are the antibodies to watch in 2013?
Reichert, J. M. (2013) · mAbs · doi:10.4161/mabs.22976 · Cited by 128
Nishimoto, N., Amano, K., Hirabayashi, Y., Horiuchi, T., Ishii, T., Iwahashi, M., Iwamoto, M., Kohsaka, H., Kondo, M., Matsubara, T., et al. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.854079 · Cited by 127
Genovese, M. C., Kinnman, N., Bourdonnaye, G. D. L., Rossi, C. P., & Tak, P. P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30373 · Cited by 123
Blum, M. A., Koo, D., & Doshi, J. A. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.06.001 · Cited by 122
Plasencia, C., Pascual‐Salcedo, D., Nuño, L., Bonilla, G., Villalba, A., Peiteado, D., Díez, J., Nagore, D., del Agua, A. R., Moral, R. M. G. D., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200828 · Cited by 122
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss, N., Noth, I., Mirsaeidi, M. S., Zhang, W., Naureckas, E. T., Hogarth, D. K., Strek, M. E., Caligiuri, P., Machado, R. F., Niewold, T. B., et al. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 119
Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis
Amari, W., Zeringue, A., McDonald, J. R., Caplan, L., Eisen, S. A., & Ranganathan, P. (2011) · Rheumatology · doi:10.1093/rheumatology/ker113 · Cited by 119
Systematic review: antibodies and anti‐ TNF ‐α levels in inflammatory bowel disease
Chaparro, M., Guerra, I., Linares, P. M., & Gisbert, J. P. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05057.x · Cited by 118
Szepietowski, J. C., Nilganuwong, S., Woźniacka, A. J., Kuhn, A., Nyberg, F., van Vollenhoven, R., Bengtsson, A. A., Reich, A., de Vries, D. E., van Hartingsveldt, B., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38091 · Cited by 117
Söderlin, M., Petersson, I. F., & Geborek, P. (2011) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.599073 · Cited by 116
Back to the future: oral targeted therapy for RA and other autoimmune diseases
O'Shea, J. J., Laurence, A., & McInnes, I. B. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.7 · Cited by 115
Self-citationSimonini, G., Druce, K. L., Cimaz, R., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22214 · Cited by 113
Pettersson, S., Lövgren, M., Eriksson, L., Moberg, C., Svenungsson, E., Gunnarsson, I., & Henriksson, E. W. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.677857 · Cited by 113
Martin, D. A., Churchill, M. A., Flores-Suárez, L. F., Cardiel, M. H., Wallace, D. J., Martin, R. W., Phillips, K., Kaine, J., Dong, H., Salinger, D. H., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4347 · Cited by 111
Osteoarthritis: can anti-cytokine therapy play a role in treatment?
Calich, A. L., Domiciano, D. S., & Fuller, R. (2010) · Clinical Rheumatology · doi:10.1007/s10067-009-1352-3 · Cited by 108
Bykerk, V., Östör, A., Álvaro-Gracia, J., Pavelka, K., Ivorra, J., Graninger, W., Bensen, W., Nurmohamed, M., Krause, A., Bernasconi, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201087 · Cited by 107
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilová, E., Aelion, J. A., Lee, S., Codding, C. E., Kellner, H. L., Ikawa, T., et al. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130637 · Cited by 105
Fallahi‐Sichani, M., Flynn, J. L., Linderman, J. J., & Kirschner, D. E. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103298 · Cited by 99
Tsai, T., Ho, V., Song, M. W., Szapary, P. O., Kato, T., Wasfi, Y. S., Li, S., Shen, Y., Leonardi, C., on behalf of the PHOENIX 1, P. 2., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11142.x · Cited by 96
Clark, W. K., Jobanputra, P., Barton, P. M., & Burls, A. (2004) · Health Technology Assessment · doi:10.3310/hta8180 · Cited by 96
Emery, P., Genovese, M. C., van Vollenhoven, R., Sharp, J. T., Patra, K., & Sasso, E. H. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081018 · Cited by 96
Deodhar, A. A., Reveille, J. D., den Bosch, F. E. V., Braun, J., Burgos‐Vargas, R., Caplan, L., Clegg, D. O., Colbert, R. A., Gensler, L. S., van der Heijde, D. M. F. M., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38776 · Cited by 95
Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis
Machado, M. A. D. Á., Barbosa, M. M., Almeida, A. M., de Araújo, V. E., Kakehasi, A. M., Andrade, E. I. G., Cherchiglia, M. L., & Acúrcio, F. D. A. (2013) · Rheumatology International · doi:10.1007/s00296-013-2772-6 · Cited by 95
Yamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2010) · Modern Rheumatology · doi:10.1007/s10165-010-0366-7 · Cited by 93
Secukinumab failure in Crohn's disease: the yeast connection?
Colombel, J., Sendid, B., Jouault, T., & Poulain, D. (2012) · Gut · doi:10.1136/gutjnl-2012-304154 · Cited by 93
Wozniak, T. M., Ryan, A. A., & Britton, W. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8684 · Cited by 92
Kirchner, S., Holler, E., Haffner, S., Andreesen, R., & Eißner, G. (2004) · Cytokine · doi:10.1016/j.cyto.2004.06.008 · Cited by 91
Role of Interleukin-1 Inhibitors in Osteoarthritis
Jotanović, Z., Mihelić, R., Šestan, B., & Dembić, Z. (2012) · Drugs & Aging · doi:10.2165/11599350-000000000-00000 · Cited by 91
Targan, S. R., Feagan, B. G., Vermeire, S., Panaccione, R., MELMED, G. Y., Blosch, C. M., Newmark, R., Zhang, N., Chon, Y., Lin, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.084 · Cited by 88
Takeuchi, T., Tanaka, Y., Amano, K., Hoshi, D., Nawata, M., Nagasawa, H., Sato, E. I., Saito, K., Kaneko, Y. S., Fukuyo, S., et al. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker221 · Cited by 88
Imagawa, T., Yokota, S., Mori, M., Miyamae, T., Takei, S., Imanaka, H., Nerome, Y., Iwata, N., Murata, T., Miyoshi, M., et al. (2011) · Modern Rheumatology · doi:10.3109/s10165-011-0481-0 · Cited by 85
van der Bijl, A. E., Breedveld, F. C., Antoni, C., Kalden, J. R., Kary, S., Burmester, G. R., Beckmann, C., Unnebrink, K., & Küpper, H. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0866-4 · Cited by 82
Long-Term Treatment with Infliximab in Patients with Sarcoidosis
Hostettler, K., Studler, U., Tamm, M., & Brutsche, M. H. (2011) · Respiration · doi:10.1159/000328738 · Cited by 82
Importance of reverse signaling of the TNF superfamily in immune regulation
Juhász, K., Buzás, K., & Duda, E. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.13.14 · Cited by 73
Stubenrauch, K. G., Wessels, U., Birnboeck, H., Ramirez, F. C., Jahreis, A., & Schleypen, J. S. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.021 · Cited by 71
Curtis, J. R., Lanas, Á., John, A. K., Johnson, D. A., & Schulman, K. L. (2012) · Arthritis Care & Research · doi:10.1002/acr.21764 · Cited by 71
Perrier, C., Hertogh, G. D., Cremer, J., Vermeire, S., Rutgeerts, P. J., Assche, G. V., Szymkowski, D. E., & Ceuppens, J. L. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23023 · Cited by 71
Solomon, D. H., Mercer, E., & Kavanaugh, A. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30653 · Cited by 71
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register
Chatzidionysiou, K., Askling, J., Eriksson, J. K., Kristensen, L. E., & van Vollenhoven, R. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204714 · Cited by 69
Weinblatt, M. E., Kremer, J. M., Cush, J. J., Rigby, W. F. C., Teng, L. L., Devenport, J. N., Singh, N., Lepley, D. M., & Genovese, M. C. (2012) · Arthritis Care & Research · doi:10.1002/acr.21847 · Cited by 64
Review: The Paediatric Rheumatology International Trials Organization (PRINTO)
Ruperto, N., Bazsó, A., Ravelli, A., Malattia, C., Filocamo, G., Pistorio, A., Lozano, A. L. R., Viola, S., & Martini, A. (2007) · Lupus · doi:10.1177/0961203307079556 · Cited by 63
Lee, S. H., Chang, H., Yazıcı, Y., et al. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080889 · Cited by 63
Stavropoulos‐Kalinoglou, A., Metsios, G. S., Panoulas, V. F., Nightingale, P., Koutedakis, Y., & Kitas, G. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3900 · Cited by 62
Pan, S. M. D., Scherer, A., Gabay, C., & Finckh, A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200882 · Cited by 61
A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
Goh, A. X., Bertin-Maghit, S., Yeo, S. P., Ho, A. W. S., Derks, H., Mortellaro, A., & Wang, C. (2014) · mAbs · doi:10.4161/mabs.28614 · Cited by 59
Yamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2011) · Modern Rheumatology · doi:10.3109/s10165-010-0366-7 · Cited by 59
van de Vosse, E., & Ottenhoff, T. H. M. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.032 · Cited by 51
Kekow, J., Müller‐Ladner, & Schulze-Koops (2012) · Biologics · doi:10.2147/btt.s32244 · Cited by 47
Treatment with biologics of pregnant patients with rheumatic diseases
Østensen, M., & Förger, F. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328344a732 · Cited by 45
Simard, J. F., Neovius, M., Askling, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34582 · Cited by 31
Aletaha, D., Alasti, F., & Smolen, J. S. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201970 · Cited by 30
Nishimoto, N., Amano, K., Hirabayashi, Y., Horiuchi, T., Ishii, T., Iwahashi, M., Iwamoto, M., Kohsaka, H., Kondo, M., Matsubara, T., et al. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.854080 · Cited by 27
Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease.
Song, I., Haibel, H., Poddubnyy, D., Braun, J., & Sieper, J. (2013) · PubMed · Cited by 21
Cited by
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases
Leyva-López, N., Gutierrez-Grijalva, E., Ambriz-Perez, D., & Heredia, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060921 · Cited by 337
The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review
Docherty, S., Harley, R., McAuley, J. J., Crowe, L. A. N., Pedret, C., Kirwan, P. D., Siebert, S., & Millar, N. L. (2022) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-022-00397-2 · Cited by 292
Self-citationBispecific antibodies and their applications
Fan, G., Wang, Z., Hao, M., & Li, J. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0227-0 · Cited by 288
NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
Guo, C., Fu, R., Wang, S., Huang, Y., Li, X., Zhou, M., Zhao, J., & Yang, N. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13167 · Cited by 285
Metadata
- Authors
- Siebert, S., Tsoukas, A., Robertson, J., & McInnes, I.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 67
- Issue
- 2
- Pages
- 280-309
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2135510881
- Cited by
- 307
- References
- 263
- FWCI
- 31.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.